Gold prices edge higher with focus on Ukraine-Russia, Jackson Hole
Investing.com - Applied Therapeutics Inc (NASDAQ: APLT) reported second quarter EPS of $-0.130, $0.03 better than the analyst estimate of $-0.164. Revenue for the quarter came in at $144K versus the consensus estimate of $3.33M.
Applied Therapeutics Inc's stock price closed at $6.10. It is up 38.950% in the last 3 months and up 304.420% in the last 12 months.
Applied Therapeutics Inc saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Applied Therapeutics Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Applied Therapeutics Inc's Financial Health score is "good performance".
Check out Applied Therapeutics Inc's recent earnings performance, and Applied Therapeutics Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar